Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Structure Revealed by Mass Spectrometry Technique

By LabMedica International staff writers
Posted on 31 May 2011
An advanced mass spectroscopy technique was used to detail the structure of a signaling protein critical to physiological processes involved in major diseases such as diabetes and cancer.

The protein, Epac2 (exchange protein directly activated by cAMP 2), is a guanine nucleotide exchange factor that regulates a wide variety of intracellular processes in response to second messenger cAMP (cyclic adenosine monophosphate).

A collaborative project was carried out by investigators at the University of Texas Medical Branch (Galveston, USA) and the University of California, San Diego (USA) to define the three-dimensional structure of Epac2 in the presence and absence of cAMP using an advanced mass spectroscopy technique known as hydrogen/deuterium exchange mass spectrometry (DXMS).

Results published in the May 20, 2011, issue of the Journal of Biological Chemistry revealed that that cAMP interacted with its two known binding sites on Epac2 in a sequential fashion and that binding of cAMP changed the shape of the protein in a very specific way. More...
This shape change was caused by a major hinge motion centered on the C- terminus of the second cAMP binding domain. This conformational change realigned the regulatory components of Epac2 away from the catalytic core, making the later available for effector binding.

"This study applied a powerful protein structural analysis approach to investigate how a chemical signal called cAMP turns on one of its protein switches, Epac2," said senior author Dr. Xiaodong Cheng, professor of pharmacology and toxicology at the University of Texas Medical Branch.

"DXMS analysis has proved to be an amazingly powerful approach, alone or in combination with other techniques, in figuring out how proteins work as molecular machines, changing their shapes – or morphing – in the normal course of their function," said contributing author Dr. Virgil Woods, professor of medicine at the University of California, San Diego. "This will be of great use in the identification and development of therapeutic drugs that target these protein motions."

Related Links:
University of Texas Medical Branch
University of California, San Diego




Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.